ジョージ進伍 山本

ジョージ進伍 山本 has extensive experience in the pharmaceutical and biotech industry, with a focus on business development and sales. ジョージ進伍 is currently working as the Director of Sales, Japan/Asia, Business Development at AmbioPharm, where they are responsible for expanding the custom peptide synthesis and formulation development business in Japan and other markets in the Asia Pacific region. Prior to this, they worked at Aenova Holding GmbH as a Senior Account Manager, where they successfully expanded the CDMO business in Japan and other Asian markets. ジョージ進伍 also served as an Executive Consultant at CAC Croit Corporation, where they played a key role in expanding the CRO business into foreign markets and establishing strategic alliances and partnerships with foreign CROs. Additionally, they worked at Catalent Pharma Solutions as the Director, Asia Pacific Business Development, where they were responsible for promoting orally disintegrating tablets based on Zydis technology and providing educational sessions to customers' marketing and sales teams. ジョージ進伍 also has experience in research planning and promotion at Seikagaku Corp and Lonza Japan Ltd, as well as licensing activities at TSUMURA & CO. Overall, Mr. Yamamoto has a strong background in driving business growth and establishing partnerships in the pharmaceutical and biotech industry.

ジョージ進伍山本 attended the College of Health Sciences at State University of Londrina in Brazil from 1982 to 1986, where they earned their Bachelor of Pharmaceutical Sciences degree. ジョージ進伍 then pursued further education at Chiba University in Japan, where they served as a student researcher in the Faculty of Pharmaceutical Sciences from 1987 to 1988. From 1988 to 1990, they completed their Master's degree in an unspecified field of study at the same institution.